Both inorganic and organic selenium supplements can decrease brain monoamine oxidase B enzyme activity in adult rats

British Journal of Nutrition

Volumn 100, Issue 3, 2008, Pages 660-665

  Tang, Ya Li ^a   Wang, Shih Wei ^a   Lin, Shyh Mirn ^a  

^a CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

Author keywords

Antioxidation; Brain; Monoamine oxidase B; Selenium; Seleno yeast

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BRAIN ENZYME; SELENITE; SELENIUM; TOCOPHEROL;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; RAT;

ANIMAL FEED; ANIMALS; ANTIOXIDANTS; BRAIN CHEMISTRY; LIPID PEROXIDATION; LIVER; MALE; MONOAMINE OXIDASE; RANDOM ALLOCATION; RATS; RATS, LONG-EVANS; SELENIUM; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS;

EID: 49649102152     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508911594     Document Type: Article

References (47)

1. Benedetti SM & Dostert P (1989) Monoamine oxidase, brain aging and degenerative diseases. Biochem Pharmacol 38, 555-561.
2. 3H]deprenyl. Brain Res 547, 69-76.
3. Nicotra A, Pierucci F, Parvez H & Senatori O (2004) Monoamine oxidase expression during development and aging. Neurotoxicology 25, 155-165.
4. Saura J, Luque JM, Cesura AM, Da Prada M, Chan-Palay V, Huber G, Loffler J & Richards JG (1994) Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62, 15-30.
5. Sherif F, Gottfries CG, Alafuzoff I & Oreland L (1992) Brain γ-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. J Neural Transm Park Dis Dement Sect 4, 227-240.
6. Knoll J (1993) The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases. J Neural Transm Suppl 40, 69-91.
7. Alafuzoff I, Helisalmi S, Heinonen EH, Reinikainen K, Hallikainen M, Soininen H & Koivisto K (2000) Selegiline treatment and the extent of degenerative changes in brain tissue of patients with Alzheimer's disease. Eur J Clin Pharmacol 55, 815-819.
8. Guay DR (2006) Rasagiline (TVP-1012): A new selective monoamine oxidase inhibitor for Parkinson's disease. Am J Geriatr Pharmacother 4 330-346.
9. Rayman MP (2000) The importance of selenium to human health. Lancet 356, 233-241.
10. Combs GF Jr (2005) Current evidence and research needs to support a health claim for selenium and cancer prevention. J Nutr 135, 343-347.
11. Ryan-Harshman M & Aldoori W (2005) The relevance of selenium to immunity, cancer, and infectious/inflammatory diseases. Can J Diet Pract Res 66, 98-102.
12. Ip C (1998) Lessons from basic research in selenium and cancer prevention. J Nutr 128, 1845-1854.
13. Finley JW (2006) Bioavailability of selenium from foods. Nutr Rev 64, 146-151.
14. Tapiero H, Townsend DM & Tew KD (2003) The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 57, 134-144.
15. Fairweather-Tait SJ (1997) Bioavailability of selenium. Eur J J Clin Nutr 51, Suppl.1, S20-S23.
16. Qin S, Gao J & Huang K (2007) Effects of different selenium sources on tissue selenium concentrations, blood GSH-PX activities and plasma interleukin levels in finishing lambs. Biol Trace Elem Res 116 91-102.
17. Vendeland SC, Deagen JT, Butler JA & Whanger PD (1994) Uptake of selenite, selenomethionine and selenate by brush border membrane vesicles isolated from rat small intestine. Biometals 7, 305-312.
18. Schweizer U, Brauer AU, Kohrle J, Nitsch R & Savaskan NE (2004) Selenium and brain function: A poorly recognized liaison. Brain Res Brain Res Rev 45, 164-178.
19. Chen J & Berry MJ (2003) Selenium and selenoproteins in the brain and brain diseases. J Neurochem 86, 1-12.
20. Batcioglu K, Karagözler AA, Ozturk IC, Genc M, Bay A, Ozturk F & Aydogdu N (2005) Comparison of chemopreventive effects of vitamin E plus selenium versus melatonin in 7,12-dimethylbenz(a)anthracene-induced mouse brain damage. Cancer Detect Prev 29, 54-58.
21. Sian J, Gerlach M, Youdim MB & Riederer P (1999) Parkinson's disease: A major hypokinetic basal ganglia disorder. J Neural Transm 106 443-476.
22. Jana S, Maiti AK, Bagh MB, Banerjee K, Das A, Roy A & Chakrabarti S (2007) Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: Implications in Parkinson's disease. Brain Res 1139, 195-200.
23. Doraiswamy PM & Xiong GL (2006) Pharmacological strategies for the prevention of Alzheimer's disease. Expert Opin Pharmacother 7 1-10.
24. Castano A, Ayala A, Rodriguez-Gomez JA, de la Cruz CP, Revilla E, Cano J & Machado A (1995) Increase in dopamine turnover and tyrosine hydroxylase enzyme in hippocampus of rats fed on low selenium diet. J Neurosci Res 42, 684-691.
25. Cao G, Alessio RM & Cutler RG (1993) Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 14, 303-311.
26. Niehaus WG & Samuelsson B (1968) Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6, 126-130.
27. McEwen CM Jr & Cohen JD (1963) An amine oxidase in normal human serum. J Lab Clin Med 62, 766-776.
28. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
29. Jacobs M & Forst C (1981) Toxicological effects of sodium selenite in Sprague-Dawley rats. J Toxicol Environ Health 8, 575-585.
30. Crosley LK, Meplan C, Nicol F, Rundlof AK, Arner ES, Hesketh JE & Arthur JR (2007) Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney. Arch Biochem Biophys 459, 178-188.
31. Uthus EO & Ross SA (2007) Dietary selenium affects homocysteine metabolism differently in Fisher-344 rats and CD-1 mice. J Nutr 137, 1132-1136.
32. Jiang C, Jiang W, Ip C, Ganther H & Lu J (1999) Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog 26, 213-225.
33. Sayar K, Ugur M, Gurdal H, Onaran O, Hotomaroglu O & Turan B (2000) Dietary selenium and vitamin E intakes alter β-adrenergic response of L-type Ca-current and β-adrenoceptor-adenylate cyclase coupling in rat heart. J Nutr 130, 733-740.
34. Wu Q, Huang K & Xu H (2003) Effects of long-term selenium deficiency on glutathione peroxidase and thioredoxin reductase activities and expressions in rat aorta. J Inorg Biochem 94, 301-306.
35. Danesi F, Malaguti M, Nunzio MD, Maranesi M, Biagi PL & Bordoni A (2006) Counteraction of adriamycin-induced oxidative damage in rat heart by selenium dietary supplementation. J Agric Food Chem 54, 1203-1208.
36. Schneider C (2005) Chemistry and biology of vitamin E. Mol Nutr Food Res 49, 7-30.
37. Kiray M, Uysal N, Sonmez A, Acikgoz O & Gonenc S (2004) Positive effects of deprenyl and estradiol on spatial memory and oxidant stress in aged female rat brains. Neurosci Lett 354, 225-228.
38. Budni P, de Lima MN, Polydoro M, Moreira JC, Schroder N & Dal-Pizzol F (2007) Antioxidant effects of selegiline in oxidative stress induced by iron neonatal treatment in rats. Neurochem Res 32, 965-972.
39. El-Demerdash FM (2001) Effects of selenium and mercury on the enzymatic activities and lipid peroxidation in brain, liver, and blood of rats. J Environ Sci Health B 36, 489-499.
40. Ognjanović BI, Marković SD, Pavlović SZ, Zikić RV, Stajn AS & Saičić ZS (2007) Effect of chronic cadmium exposure on antioxidant defense system in some tissues of rats: Protective effect of selenium Physiol Res (Epublication 25 April 2007).
41. El-Demerdash FM (2004) Antioxidant effect of vitamin E and selenium on lipid peroxidation, enzyme activities and biochemical parameters in rats exposed to aluminium. J Trace Elem Med Biol 18, 113-121.
42. Raciti G, Mazzone P, Raudino A, Mazzone G & Cambria A (1995) Inhibition of rat liver mitochondrial monoamine oxidase by hydrazine-thiazole derivatives: Structure-activity relationships. Bioorg Med Chem 3, 1485-1491.
43. 2 toxicity. J Appl Physiol 71, 1057-1061.
44. Nagatsu T & Sawada M (2006) Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: Possible implications of glial cells. J Neural Transm Suppl 71, 53-65.
45. Youdim MB & Bakhle YS (2006) Monoamine oxidase: Isoforms and inhibitors in Parkinson's disease and depressive illness. Br J Pharmacol 147, Suppl. 1, S287-S296.
46. Mandel S, Weinreb O, Amit T & Youdim MB (2005) Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Res Brain Res Rev 48, 379-387.
47. Sagi Y, Drigues N & Youdim MB (2005) The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to 1-dopa and 1-tryptophan, in rats. Br J Pharmacol 146, 553-560.